Search bioRxiv⌕ Search

bioRxiv · 10.1101/2021.05.05.442826

Immune priming can prevent WNV establishment in Culex quinquefasciatus mosquitoes: evidence for immune priming based reversal of WNV-mediated immune suppression.

Abstract

Mosquito-borne infectious diseases cause wide-spread loss of life and livelihood often in low-income settings. However, control of mosquito-vectored viral diseases such as West Nile virus (WNV) and Japanese encephalitis virus (JEV) remains challenging. Here we use an existing feature of the insect immune system to effectively vaccinate Culex quinquefasciatus mosquitoes against WNV infection. We find that priming mosquitoes by exposure to inactivated WNV reduces their likelihood of developing transmissible infections of WNV after live infection. We used RNA sequencing to identify gene expression in response to WNV and JEV infection, and the role of prior priming exposure on constitutive and induced expression on infection. Infection with either Flavivirus causes broad suppression of gene expression. WNV and JEV infection resulted in suppression of different suites of genes with notable immune genes, such as antimicrobial peptides, being strongly suppressed on WNV infection. We hypothesise that the increased resistance to WNV infection seen in primed mosquitoes may be the result of priming nullifying the immune suppression found in non-primed WNV-fed mosquitoes, potentially through greater expression of mRNA regulatory genes such as cap-binding proteins in primed mosquitoes. Author summaryMosquitoes vector many devastating infectious diseases. Two such vectored viral diseases are West Nile virus (WNV) and Japanese encephalitis virus (JEV). Control of these diseases remains challenging, and no vaccine exists for WNV. Here, we tested whether we could instead vaccinate the mosquitoes against WNV. By injecting mosquitoes with dead WNV we found that we could reduce the number of infected mosquitoes by half. We then used whole-genome RNA sequencing to identify which genes are transcribed, which will help us understand genes that are important for this form of insect immune priming, and for responses to normal WNV and JEV infection. We found that WNV suppresses the expression of many immune genes but these genes are expressed normally in vaccinated mosquitoes. Our findings expand our understanding of mosquito infection with these viruses but also demonstrate how prior exposure to a disease can produce lasting protection.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Blagrove, M., Barribeau, S. M.. 2021-05-05. Immune priming can prevent WNV establishment in Culex quinquefasciatus mosquitoes: evidence for immune priming based reversal of WNV-mediated immune suppression.. https://doi.org/10.1101/2021.05.05.442826

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

PfPHAST: Plasmodium falciparum Public Health Amplicon Sequencing Tool, a Streamlined Panel for Malaria Genomic Surveillance

Genomic tools can support malaria control policy through surveillance of Plasmodium falciparum populations, tracking antimalarial drug resistance, pfhrp2/3 deletions that compromise rapid diagnostic tests, and selection at the circumsporozoite protein (PfCSP) vaccine target, as well as through molecular correction of therapeutic efficacy studies (TES). Multiplex Amplicons for Drug, Diagnostic, Diversity, and Differentiation Haplotypes using Targeted Resequencing (MAD4HatTeR), a comprehensive amplicon sequencing panel covering up to 276 targets, supports these applications but is tailored to research rather than routine programmatic use. We developed P. falciparum Public Health Amplicon Sequencing Tool (PfPHAST), a 56-target derivative of MAD4HatTeR spanning drug resistance loci, pfhrp2/3 deletion, PfCSP genotyping, non-falciparum species identification, and 20 high-heterozygosity microhaplotype loci for TES classification. We compared PfPHAST and MAD4HatTeR using laboratory strain controls, including two-strain dilution series and a five-strain mixture, across parasite densities of 100 to 10,000 parasites/L. At matched per-target depth, PfPHAST achieved a higher quality-control pass rate than MAD4HatTeR (94.4% versus 90.0%) and distributed reads more evenly across targets. The panels showed comparable recall and precision for drug resistance codons and microhaplotypes, reaching near-complete recall above 40% within-sample allele frequency (WSAF) at all densities, with reduced sensitivity for minor alleles below 10% WSAF at low parasite density in both panels. Observed and expected WSAF correlated strongly for both panels, and both resolved a five-strain polyclonal mixture, including a 5% minor strain. By concentrating sequencing capacity on targets of greatest programmatic relevance, PfPHAST offers a scalable, lower-cost alternative to comprehensive research panels without sacrificing performance on shared targets, complementing MAD4HatTeR for routine molecular malaria surveillance.

genomics↗

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗

RNA isoform-resolved multiplexed sequencing with bioorthogonal barcoding

RNA isoform dysregulation drives disease pathogenesis and is the target of FDA-approved splice-switching therapeutics. However, multiplexed sequencing methods discard splice junction information because only 3' termini are barcoded and counted. Here, we repurpose acylation and click chemistries to conjugate bioorthogonal barcodes (bobcodes) directly onto multiple internal positions along cellular RNAs. Bobcoded RNAs from multiple samples are pooled for multiplexed cDNA synthesis, during which reverse transcriptase switches from each RNA template onto its tethered bobcode with greater than 99% accuracy in species mixing experiments. Bobcode attachment intervals set cDNA insert sizes without a library fragmentation step, and priming with poly(dT) or random hexamers selects between 3'-end counting and full-length isoform capture. A bioorthogonal barcode-sequencing (BOB-seq v0.1) drug screen identifies transcriptome-wide on- and off-target RNA splicing effects and outperforms existing multiplexing RNA sequencing methods in workflow simplicity, sample-to-sample variability, and barcoding accuracy. Bobcodes add isoform resolution to scalable multiplexed RNA sequencing.

genomics↗